Dr. Anthony J. Sielicki, MD

Dr. Sielicki practices at Jefferson Einstein Philadelphia Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University.

Dr. Sielicki's NPI, 1619339520, was assigned on March 22, 2016. Dr. Sielicki holds Pennsylvania license MD466921.

Dr. Sielicki's primary practice is Jefferson Einstein Philadelphia Hospital, at 5501 Old York Road, Philadelphia, PA 19141 in Philadelphia County. The practice phone is (215) 456-6090.

Dr. Sielicki's primary practice is Jefferson Einstein Philadelphia Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University. Dr. Sielicki is also affiliated with Thomas Jefferson University Hospital. The medical group on file is Jefferson University Physicians. Dmand AI also links Dr. Sielicki to 2 more hospitals, 4 medical groups and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sielicki practices, 5 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Sielicki's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Sielicki is licensed in Pennsylvania.

CMS data shows 349 Medicare services from Dr. Sielicki across 5 procedure codes in 2024, for 249 Medicare patients. Medicare paid $31,562 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 249 Medicare patients who saw Dr. Sielicki in 2024. The largest group is 65 to 74, with 98 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 54% are also on Medicaid. Their average risk score is 2.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sielicki's median patient age at 45, with 55% women.

In 2024, Dr. Sielicki wrote 74 Medicare Part D claims for 52 patients. 92% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $22 in total drug cost. In 2017, CMS named 13 claims across 1 drug.

Dr. Sielicki accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Sielicki, published from 2020 to 2022. 2020 was the busiest year, with 3. The most frequent topics are Emergency Medicine and Internship and Residency. Dr. Sielicki has published most often in Cureus. Dr. Sielicki's most frequent co-authors are Robin Michelle Naples, MD, Megan Crossman and Michael Kiemeney, MD.

CMS Open Payments shows 1 general payment to Dr. Sielicki from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. UCB, Inc. paid the most, $22.